Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -32404.78% is 343244% below its 4-year average of -9.44%, near the low end of its 4-year range (-32404.78%–0.00%).
137237.49% below its 12-month average of -23.59%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -8207.96%.
RETURN ON ASSETS (ROA)
-32404.78%
RETURN ON ASSETS (ROA) AVG TTM
-23.59%
RETURN ON ASSETS (ROA) AVG 3Y
-11.80%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-137237.49%
CURRENT VS 3Y AVG
-274574.97%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.81%
median of 819 covered companies
CURRENT VS SECTOR MEDIAN
-101769.79%
vs the sector median at left
NOMAD Power Solutions, Inc.
Market Cap
$51.79M
Return on Assets (ROA)
-32404.78%
TTM Avg
-23.59%
3Y Avg
-11.80%
5Y Avg
N/A
Market Cap
$52.27M
Return on Assets (ROA)
5.76%
TTM Avg
13.86%
3Y Avg
7.25%
5Y Avg
29.75%
Market Cap
$52.66M
Return on Assets (ROA)
-48.49%
TTM Avg
-50.18%
3Y Avg
-39.97%
5Y Avg
-38.29%
Market Cap
$51.61M
Return on Assets (ROA)
-49.54%
TTM Avg
-66.28%
3Y Avg
-54.88%
5Y Avg
-41.21%
Market Cap
$51.42M
Return on Assets (ROA)
-127.67%
TTM Avg
-99.17%
3Y Avg
-76.90%
5Y Avg
-71.83%
Market Cap
$50.95M
Return on Assets (ROA)
-97.71%
TTM Avg
-228.91%
3Y Avg
-360.64%
5Y Avg
-295.62%
Market Cap
$53.63M
Return on Assets (ROA)
-34.52%
TTM Avg
-27.74%
3Y Avg
-32.72%
5Y Avg
-28.49%
Market Cap
$50.80M
Return on Assets (ROA)
-53.31%
TTM Avg
-34.34%
3Y Avg
-114.79%
5Y Avg
-190.75%
Market Cap
$50.61M
Return on Assets (ROA)
-171.51%
TTM Avg
-144.24%
3Y Avg
-112.57%
5Y Avg
-82.33%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NOMAD Power Solutions, Inc. (NMAD) | $51.79M | -32404.78% | -23.59% | -11.80% | N/A |
| biote Corp. (BTMD)vs › | $52.27M | 5.76% | 13.86% | 7.25% | 29.75% |
| Aldeyra The (ALDX)vs › | $52.66M | -48.49% | -50.18% | -39.97% | -38.29% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.61M | -49.54% | -66.28% | -54.88% | -41.21% |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | -127.67% | -99.17% | -76.90% | -71.83% |
| Envoy Medical, Inc. (COCH)vs › | $50.95M | -97.71% | -228.91% | -360.64% | -295.62% |
| ImageneBio Inc (IMA)vs › | $53.63M | -34.52% | -27.74% | -32.72% | -28.49% |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.80M | -53.31% | -34.34% | -114.79% | -190.75% |
| Clene Inc. (CLNN)vs › | $50.61M | -171.51% | -144.24% | -112.57% | -82.33% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.45M | N/A | -109.69% | -346.56% | -277.44% |
ROA
-32404.8%
ROE
-36114.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -47.19% |
| 2024-12-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2021-12-31 | 0.00% |
